ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
ALX Oncology (ALXO) announced the appointment of Jeff Knight as chief development and operating officer, effective April 13. Most recently, he served as chief development and operating officer at Crinetics (CRNX).
